[March 18, 2015] |
|
Research and Markets: Global Obesity Therapeutics Pipeline Review 2015 - Featuring 94 Companies
Research and Markets (http://www.researchandmarkets.com/research/hgpvpz/obesity)
has announced the addition of the "Obesity
- Pipeline Review, H1 2015" report to their offering.
This report provides comprehensive information on the therapeutic
development for Obesity, complete with comparative analysis at various
stages, therapeutics assessment by drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type, along with
latest updates, and featured news and press releases. It also reviews
key players involved in the therapeutic development for Obesity and
special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Key Topics Covered:
-
Introduction
-
Obesity Overview
-
Therapeutics Development
-
Obesity - Therapeutics under Development by Companies
-
Obesity - Therapeutics under Investigation by Universities/Institutes
-
Obesity - Pipeline Products Glance
-
Obesity - Products under Development by Companies
-
Obesity - Products under Investigation by Universities/Institutes
-
Obesity - Companies Involved in Therapeutics Development
-
Obesity - Therapeutics Assessment
-
Drug Profiles
-
Obesity - Recent Pipeline Updates
-
Obesity - Dormant Projects
-
Obesity - Discontinued Products
-
Obesity - Product Development Milestones
-
Appendix
Companies Mentioned
-
Advinus Therapeutics Ltd.
-
Amgen Inc.
-
Eli Lilly and Company
-
Esperion Therapeutics, Inc.
-
Euroscreen S.A.
-
F. Hoffmann-La Roche Ltd.
-
Galapagos NV
-
Galenea Corp.
-
Genfit SA
-
GlaxoSmithKline plc
-
GTx, Inc.
-
Handok Inc.
-
Hanmi Pharmaceuticals, Co. Ltd.
-
Helsinn Healthcare S.A.
-
High Point Pharmaceuticals, LLC
-
Insusense Therapeutics ApS
-
Intarcia Therapeutics, Inc.
-
Isis Pharmaceuticals, Inc.
-
Jenrin Discovery, Inc.
-
Johnson & Johnson
-
Kainos Medicine, Inc.
-
Kissei Pharmaceutical Co., Ltd.
-
Lead Discovery Center GmbH
-
LG Life Sciences, Ltd.
-
Mitsubishi (News - Alert) Tanabe Pharma Corporation
-
Molecular Design International, Inc.
-
Neothetics, Inc.
-
P2D Bioscience
-
Pfizer Inc.
-
PharmaIN Corporation
For more information visit http://www.researchandmarkets.com/research/hgpvpz/obesity
[ Back To TMCnet.com's Homepage ]
|